• Gepotidacin (GSK2140944): Applied Protocols for Antibacteria

  2026-04-22

  Gepotidacin, a pioneering triazaacenaphthylene antibiotic, empowers researchers to address antibiotic resistance through selective bacterial DNA replication inhibition. This article spotlights actionable workflows, advanced troubleshooting, and translational insights to maximize Gepotidacin’s value in both in vitro and in vivo antibacterial research.

• Carfilzomib (PR-171): Transforming Proteasome Inhibition Wor

  2026-04-22

  Carfilzomib (PR-171) delivers unmatched precision and potency as an irreversible proteasome inhibitor, enabling multi-modal cell death research and effective radiosensitization in cancer models. This guide integrates cutting-edge findings and lab-validated protocols, equipping researchers to unlock new frontiers in proteasome-mediated proteolysis inhibition and beyond.

• hiPSC-Derived Intestinal Organoids Advance Pharmacokinetic M

  2026-04-21

  This study presents a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids that authentically recapitulate intestinal epithelial function. The findings have significant implications for pharmacokinetic studies and drug metabolism assays, offering an improved alternative to established cell lines and animal models.

• CLCC1 Enables Membrane Fusion in Herpesvirus Nuclear Egress

  2026-04-21

  This study identifies the chloride channel CLCC1 as an essential host factor enabling membrane fusion during herpesvirus nuclear egress, a step previously lacking a defined mediator. Through a genome-wide CRISPR screen and mechanistic validation, the work uncovers a conserved membrane remodeling pathway with implications for viral replication and nuclear envelope biology.

• Epinephrine Bitartrate: Applied Protocols and Troubleshootin

  2026-04-20

  Epinephrine Bitartrate from APExBIO stands out as a versatile adrenergic receptor agonist, enabling robust experimental design in cardiovascular and neurobiology research. Explore stepwise workflows, advanced troubleshooting, and protocol refinements designed to maximize reproducibility and translational insight.

• Helicobacter pylori-Induced HNF4A Silencing Drives Gastric C

  2026-04-20

  This study uncovers that Helicobacter pylori infection induces hypermethylation and silencing of HNF4A, a tumor suppressor, in gastric epithelial cells. The loss of HNF4A disrupts epithelial polarity and activates EMT signaling, facilitating gastric tumorigenesis and metastasis, with implications for targeting epigenetic regulation in cancer research.

• c-Myc tag Peptide: Mechanistic Insights and Assay Precision

  2026-04-19

  Explore the c-Myc tag Peptide as a precision reagent for immunoassays, with a deep dive into its molecular mechanism and new insights from transcription factor regulation studies. This article uniquely connects c-Myc tag peptide workflow optimization with recent advances in innate immune signaling.

• AMD-070 Hydrochloride: Advanced CXCR4 Antagonist Workflows

  2026-04-18

  Mavorixafor hydrochloride (AMD-070 hydrochloride) is transforming the way researchers interrogate the CXCR4/CXCL12 axis, enabling both rare immunodeficiency studies and anti-HIV research with robust, reproducible inhibition. This article delivers scenario-driven protocols, troubleshooting insights, and direct translation of phase 3 clinical evidence into practical laboratory guidance.

• Dacarbazine as an Antineoplastic Chemotherapy Drug: Workflow

  2026-04-17

  Dacarbazine stands out in cancer research for its robust DNA alkylation mechanism, high reproducibility, and proven efficacy in treating malignant melanoma, Hodgkin lymphoma, and sarcoma. This guide delivers actionable workflow enhancements, troubleshooting strategies, and protocol parameters for maximizing experimental success with APExBIO’s Dacarbazine.

• LncRNA MRF Inhibits BMSC Osteogenesis via cAMP-PKA-CREB Path

  2026-04-16

  Ning et al. (2025) reveal that the long non-coding RNA MRF suppresses osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) by targeting FSHR and modulating the cAMP-PKA-CREB signaling cascade. This work elucidates a new regulatory axis relevant to osteoporosis and bone defect repair, offering a foundation for future therapeutic strategies.

• Vernakalant Hydrochloride (SKU A3915): Reliable Data-Driven

  2026-04-15

  This article addresses practical challenges faced by biomedical researchers and lab technicians conducting AF assays or ion channel studies, demonstrating how Vernakalant Hydrochloride (SKU A3915) offers reproducible, evidence-backed solutions. By integrating peer-reviewed data and real-world laboratory scenarios, we highlight how this compound facilitates sensitive, selective, and workflow-safe experimentation.

• 3D Organoid-Fibroblast Models Reveal Chemoresistance in PDAC

  2026-04-14

  Schuth et al. developed a patient-specific 3D co-culture model combining pancreatic tumor organoids with matched cancer-associated fibroblasts (CAFs), directly demonstrating stromal contributions to chemoresistance in pancreatic ductal adenocarcinoma (PDAC). This work provides a technically rigorous framework for dissecting tumor-stroma interactions, with broad implications for personalized drug screening and mechanistic studies.

• Epidemiology and Drug Resistance of C. auris in South China

  2026-04-13

  This study provides the first in-depth molecular epidemiological analysis of Candidozyma auris isolates in Guangzhou, South China, revealing distinct clade distributions, antifungal resistance profiles, and virulence mechanisms. The findings have immediate implications for infection control, surveillance, and antifungal stewardship in healthcare settings.

• Adefovir (GS-0393): Mechanistic Advances and Translational S

  2026-04-12

  This thought-leadership article unpacks the molecular underpinnings and translational relevance of Adefovir (GS-0393) in hepatitis B virus (HBV) research, offering actionable guidance for experimentalists. It blends mechanistic analysis, protocol optimization, and clinical context—anchored in the latest evidence and workflow recommendations. Drawing on APExBIO's Adefovir offering, the article uniquely bridges foundational insights with forward-looking lab strategies, surpassing standard product-centric content.

• ddATP in DNA Damage and Repair: Beyond Sanger Sequencing

  2026-04-12

  Explore the pivotal role of ddATP (2',3'-dideoxyadenosine triphosphate) in advanced DNA repair and replication studies. This article goes beyond classic sequencing uses, uncovering recent mechanistic insights and practical assay implications.

16511 records 1/1101 page Next 12345 下5页 Last page